Girao Tiago

Girao Tiago is listed in filings as Chief Financial Officer at Immunovant, Inc.. This profile follows SEC Form 4 activity through Apr 24, 2026, including sale activity. Recent filings connect the profile to Immunovant, Inc. (IMVT). The current snapshot covers public activity from May 5, 2025 to Apr 24, 2026. Reported amounts are shown as $4.7M to $763.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.